3D Printing Revolutionizes Medicine: How Personalized Implants Are Transforming Healthcare Worldwide

The medical field is undergoing a significant transformation due to advancements in 3D printing, with rising interest in custom-made implants, surgical instruments, and prosthetic devices. Companies focused on additive manufacturing are experiencing notable increases in revenue, with industry leaders such as

(NASDAQ: MTLS) and Saudi Arabia’s National Additive Manufacturing Innovation Company (NAMI) at the forefront. This progress is further supported by the expanding market for 3D printing gases, which play a vital role in ensuring both cleanliness and accuracy in the production of medical-grade items.

Materialise, a Belgian company well-known for its 3D printing software and healthcare solutions, achieved a record quarterly revenue of €33.3 million ($38.8 million) in Q3 2025, reflecting a 10.3% year-over-year rise in its Medical division, as reported by

. This segment, which covers tailored implants and surgical planning products, now represents half of the company’s overall income. CEO Brigitte de Vet-Veithen credited this success to the growing use of 3D-printed solutions in healthcare, especially in orthopedics and dental care. Even with broader challenges in the industrial 3D printing sector, the 3DPrint.com report highlighted that the company remained profitable, recording a net profit of €1.8 million ($2 million) for the quarter.

The growth of 3D printing in medicine is also being propelled by the global market for 3D printing gases, which is forecasted to expand at a compound annual growth rate of 6.5% between 2025 and 2030. Inert gases such as argon, nitrogen, and helium are crucial for creating stable printing environments, ensuring both precision and sterility in medical manufacturing, according to

. The healthcare sector alone is anticipated to see a CAGR of 6.3%, fueled by the demand for individualized implants and advancements in bioprinting. This momentum is especially strong in the Asia Pacific region, where countries like China and India are rapidly integrating 3D printing into healthcare as part of national industrial strategies.

In Saudi Arabia, NAMI—a partnership between 3D Systems and local collaborators—recently marked three significant achievements in the aerospace and defense industries, as detailed by

. The company landed a $26 million deal with Modern Isotopes Factory to manufacture tungsten core parts for non-destructive testing equipment, replacing conventional uranium-based components. NAMI also joined forces with Saudi Electric Company to bring 3D printing into energy sector operations and worked with Lockheed Martin to produce essential aerospace parts locally. These initiatives align with Saudi Arabia’s Vision 2030, which aims to diversify the nation’s industrial landscape and establish it as a leader in advanced manufacturing.

Materialise further strengthened its market presence by announcing a secondary listing on Euronext Brussels in November 2025, adding to its current Nasdaq listing, as reported by

. This strategic move is intended to attract a wider range of investors and improve stock liquidity, reflecting the company’s focus on financial agility as the 3D printing sector matures. The announcement coincided with a proposed $30 million share repurchase plan, demonstrating confidence in future growth despite a 22% drop in share value so far this year. Experts suggest that being listed on two exchanges will help compete more robustly with companies like 3D Systems and Stratasys, especially as they invest heavily in expansion.

Although the medical 3D printing sector continues to face obstacles such as high gas expenses and regulatory complexities, its adaptability is clear in the way companies continue to innovate and remain profitable. As healthcare organizations increasingly focus on personalized treatments and just-in-time manufacturing, the adoption of 3D printing in clinical settings is expected to accelerate, further establishing its importance in modern medicine.